000 01347 a2200433 4500
005 20250515064342.0
264 0 _c20070626
008 200706s 0 0 eng d
022 _a0017-8748
024 7 _a10.1111/j.1526-4610.2007.00763_3.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Ho Lun
245 0 0 _aTopiramate for migraine prophylaxis among Chinese population.
_h[electronic resource]
260 _bHeadache
_cApr 2007
300 _a616-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdult
650 0 4 _aAsian People
650 0 4 _aFemale
650 0 4 _aFructose
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMigraine Disorders
_xepidemiology
650 0 4 _aNeuroprotective Agents
_xtherapeutic use
650 0 4 _aObservation
650 0 4 _aProspective Studies
650 0 4 _aTime Factors
650 0 4 _aTopiramate
700 1 _aKwan, Patrick
700 1 _aLeung, Howan
700 1 _aYu, Evelyn
700 1 _aTsoi, Tak Hong
700 1 _aHui, Andrew Che Fai
700 1 _aSheng, Bun
700 1 _aLau, Kwok Kwong
773 0 _tHeadache
_gvol. 47
_gno. 4
_gp. 616-9
856 4 0 _uhttps://doi.org/10.1111/j.1526-4610.2007.00763_3.x
_zAvailable from publisher's website
999 _c16995060
_d16995060